Position statement on substance-related disorders
Abstract
Substance-related disorders are widespread among the general public and are often accompanied by other psychiatric disorders. However, historical social stigma and other factors have led to underdiagnosis and limited access to care. Cost-effective treatment is best delivered in a comprehensive, flexible continuum of services, which should be accessible on the same basis as other medical care. The American Psychiatric Association should continue to promote access to care, high- quality treatment, education, training, research, parity in third-party coverage, and equal treatment for patients suffering from addictive disorders. This statement was drafted by the Task Force on Psychiatric Services for Addicted Patients. It was approved by the Assembly in November 1995 and by the Board of Trustees in December 1995.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
